Jaswinder Ghuman, MD serves as Autism Expert and Child and Adolescent Psychiatry Faculty for AZLEND. She is an Associate Professor of Psychiatry and Pediatrics with specialty in Child and Adolescent Psychiatry and a Subspecialty in Infant and Preschool Psychiatry. She is the Director of the Infant and Preschool Program in the Division of Child and Adolescent Psychiatry at the University of Arizona (UA). Dr. Ghuman is board certified both in general psychiatry and child and adolescent psychiatry. She has over 20 years experience in evaluating and treating children with developmental disabilities and provides clinical services to preschool children with developmental and psychiatric disorders through the Infant and Preschool Clinic at the UA and the UA extension clinic. She received an NIMH sponsored Minority Supplement grant and developed a parent and teacher questionnaire, Ghuman-Folstein Screen for Social Interaction, to screen for social interaction in 6 months to 5 year olds with autism, PDD and other developmental disorders. She was awarded an NIMH sponsored Mentored Patient Oriented Research Career Development Training Award for Clinicians (K23) to investigate the efficacy and safety of methylphenidate in treatment of ADHD symptoms in young children with ASD. She conducted a feasibility study of behavioral training to teach how to swallow pills to preschool children with Autistic Disorder followed by a double-blind, randomized, placebo-controlled, crossover study to investigate efficacy and safety of methylphenidate in preschool children with ASD and symptoms of ADHD. She was co-investigator in the multisite risperidone, methylphenidate, and guanfacine study in children who have PDD for the NIMH sponsored Autism RUPP Network and is conducting treatment studies in children with PDD and ADHD.
